CNBC Power Lunch March 20, 2015
Alzheimers disease. Call your attention to one stock. Those would be the shares of biojin right now up 7 . Up 30 in the past three months at alltime highs now after releasing very encouraging data on an experimental alzheimers drug. Telling us about it at this time yesterday and shes now back with more detail. Hi, meg. Hi tyler. Incredibly High Expectations for this drug leading into today and analysts say biogin met and exceeded them. Shocking investors saying the medicine appeared to slow the cognitive declines associated with alzheimers and today how well the drug appeared to work both on m...